Sculptra is an injectable dermal filler composed of poly-L-lactic acid (PLLA), a synthetic, biodegradable polymer that stimulates collagen production and provides gradual, long-lasting volumization for facial and body rejuvenation.

Sculptra is FDA-approved for the correction of facial lipoatrophy, particularly in HIV patients, and for treating nasolabial fold contour deficiencies and other facial wrinkles. Its mechanism of action is unique among fillers: rather than providing immediate volume, it induces a controlled inflammatory response that stimulates fibroplasia and neocollagenesis, resulting in gradual and sustained improvement in soft tissue volume and skin quality over several months.[1][2][3]

Clinical results show that Sculptra’s effects typically last 18–24 months, with some studies reporting maintenance of correction for up to 3 years with additional sessions.[4][5][6][3] Treatment usually involves a series of injections spaced several weeks apart, with the average patient requiring 2–3 sessions for optimal results.[1][7] Proper reconstitution, injection technique, and post-injection massage are critical to minimize adverse events such as nodule or papule formation, which are generally rare and non-pathological when guidelines are followed.[8][7]

Sculptra is biocompatible, nonimmunogenic, and does not require allergy testing. It is also used off-label for body rejuvenation, including the hands, neck, décolleté, abdomen, and gluteal area, with promising results.[9] Patient satisfaction rates are high, and complications are infrequent when administered by trained professionals.[1][3]

In summary, Sculptra is a safe, minimally invasive, biostimulatory filler that provides gradual, natural-looking, and long-lasting volumization by stimulating collagen regeneration.[10][2][11]

References

1. Nonsurgical Rejuvenation of the Aging Face With Injectable Poly-L-Lactic Acid for Restoration of Soft Tissue Volume. Schierle CF, Casas LA. Aesthetic Surgery Journal. 2011;31(1):95-109. doi:10.1177/1090820X10391213.
2. Polylactic Acid-Based Polymers Used for Facial Rejuvenation: A Narrative Review. Wang M, Chihchieh L, Hou M, et al. Aesthetic Plastic Surgery. 2025;49(9):2315-2327. doi:10.1007/s00266-024-04543-8.
3. Treatment of HIV Lipoatrophy and Lipoatrophy of Aging With Poly-L-Lactic Acid: A Prospective 3-Year Follow-Up Study. Levy RM, Redbord KP, Hanke CW. Journal of the American Academy of Dermatology. 2008;59(6):923-33. doi:10.1016/j.jaad.2008.07.027.
4. Facial Volumetric Correction With Injectable Poly-L-Lactic Acid. Vleggaar D. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]. 2005;31(11 Pt 2):1511-7; discussion 1517-8. doi:10.2310/6350.2005.31236.
5. Facial Enhancement and the European Experience With Sculptra (Poly-L-Lactic Acid). Vleggaar D, Bauer U. Journal of Drugs in Dermatology : JDD. 2004 Sep-Oct;3(5):542-7.
6. Sculptra: The New Three-Dimensional Filler. Sherman RN. Clinics in Plastic Surgery. 2006;33(4):539-50. doi:10.1016/j.cps.2006.09.001.
7. Injectable Poly-L-Lactic Acid (Sculptra): Technical Considerations in Soft-Tissue Contouring. Lam SM, Azizzadeh B, Graivier M. Plastic and Reconstructive Surgery. 2006;118(3 Suppl):55S-63S. doi:10.1097/01.prs.0000234612.20611.5a.
8. Dispelling the Myth: Appropriate Use of Poly-L-Lactic Acid and Clinical Considerations. Lowe NJ. Journal of the European Academy of Dermatology and Venereology : JEADV. 2006;20 Suppl 1:2-6. doi:10.1111/j.1468-3083.2006.01515.x.
9. Off Face Usage of Poly-L-Lactic Acid for Body Rejuvenation. Jabbar A, Arruda S, Sadick N. Journal of Drugs in Dermatology : JDD. 2017;16(5):489-494.
10. The “Skinny”on Sculptra: A Practical Primer to Volumization With Poly-L-Lactic Acid. Palm M, Chayavichitsilp P. Journal of Drugs in Dermatology : JDD. 2012;11(9):1046-52.
11. Engineered Collagen/Plla Composite Fillers to Induce Rapid and Long-Term Collagen Regeneration. Chang S, Zhao M, Gao W, Cao J, He B. Journal of Materials Chemistry. B. 2025;13(3):904-917. doi:10.1039/d4tb02159b.